LYCOS RETRIEVER 
Remicade: Cancers
built 626 days ago
Clinical evidence has shown that Remicade can have dangerous, potentially deadly side effects. If you have questions or would like more information about Remicade and gastrointestinal cancer, an experienced attorney may be able to help you . Contact us for a FREE consultation with a caring and competent attorney if you or someone you love has suffered serious injury as a result of taking Remicade.
Source:
A 2004 study found that rheumatoid arthritis patients who took Remicade were three times more likely to develop lymphoma, a cancer that affects the lymphatic system. Furthermore the study found that patient''s suffering from Crohn''s disease and/or rheumatoid arthritis who took Remicade had a six-fold increase of developing Remicade lymphoma .
Source:
Remicade may be linked to increased instances of the blood cancer lymphoma. Lymphoma is a cancer of the lymphatic system. Reports have indicated that Remicade may increase the risk of lymphoma three-fold, when compared to people not taking the medicine. In 2004, the FDA asked Centocor to include a warning for Remicade, identifying the possible increased risk of lymphoma.
Source:
Earlier studies have found a link between Remicade and lymphoma, pneumonia and tuberculosis. The Mayo Clinic study found a connection between Remicade and the development of skin, gastrointestinal, breast and lung cancer. Centocor claims the May Clinic study results are not accurate and that the data is flawed. The manufacturer suggests that regardless of any potentially life-threatening side effects, Remicade’s benefits outweigh any risks.
Source:
Patients taking Remicade (Generic:Infliximab) for rheumatoid arthritis suffered a type of cancer, lymphoma, at three times the rate of the general public, manufacturer Centocor warned. Centocor, a subsidiary of Johnson & Johnson, said the lymphoma incidence rate was six times higher among all patients who took the monoclonal antibody in completed clinical trials.
Source:
A recent study published in the Journal of the American Medical Association found a rather substantial link between Remicade and gastrointestinal cancer. The findings show that patients taking Remicade face triple the risk for developing gastrointestinal cancer as well as several others.
Source:
MORE ABOUT
Cancers